FRBNW | Forbion European Acquisition Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.7400 - 0.7400
52 Week Range	0.7400 - 0.7400
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	15,258
Average Volume	N/A
Shares Outstanding	12,650,000
Market Cap	9,361,000
Sector	Financial Services
Industry	Shell Companies
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	0
Country	USA

Forbion European Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe. The company was incorporated in 2021 and is based in Wilmington, Delaware.

FRBNW's peers: NHIC

*Chart delayed

Analyzing fundamentals for FRBNW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see FRBNW Fundamentals page.

Watching at FRBNW technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, but short-term trend is bearish. More technicals details can be found on FRBNW Technicals page.